Skip to Content

SIGN IN

Novartis
RANK225

Lists ranking Novartis

World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list

Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list

Latest news for Novartis

Will the pharmaceutical industry keep collaborating after COVID-19? Novartis and Bristol Myers Squibb CEOs say it has to

By

David Z. Morris

July 7, 2020 8:06 PM UTC

Novartis CEO explains why the wait for a coronavirus vaccine is so long

By

June 2, 2020 9:30 AM UTC

Why a drug that costs $2.1 million per dose is on a sales streak

By

January 29, 2020 10:42 PM UTC

Novartis’ $9.7 Billion Deal Sets off Heart Drug Wars

By

November 25, 2019 11:44 PM UTC

Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.

By

and

November 25, 2019 9:59 AM UTC

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.